Howard Hughes Medical Institute’s Liberty Latin America Class C LILAK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q4
Sell
-3,007
Closed -$72K 162
2016
Q3
$72K Buy
3,007
+54
+2% +$1.45K 0.02% 140
2016
Q2
$82K Buy
2,953
+2,524
+588% +$83.8K 0.03% 138
2016
Q1
$14K Sell
429
-632
-60% -$20.1K ﹤0.01% 155
2015
Q4
$39K Buy
+1,061
New +$34.6K 0.01% 154

Other funds holding LILAK

Howard Hughes Medical Institute's LILAK Position: Q4 2016 in Review

Howard Hughes Medical Institute sold out of Liberty Latin America Class C (LILAK) in Q4 2016, closing a stake of 3,007 shares — an estimated $72K sold.

Howard Hughes Medical Institute first reported a position in LILAK in Q4 2015 and held it in 4 quarters. The position peaked at $82K in Q2 2016. 239 funds tracked by Wall St. Rank hold LILAK as of Q4 2016.

  • Howard Hughes Medical Institute reported no remaining Liberty Latin America Class C position as of Q4 2016 after selling out during the quarter.
  • Howard Hughes Medical Institute sold 3,007 Liberty Latin America Class C shares in Q4 2016, an estimated $72K.
  • Howard Hughes Medical Institute first reported a position in Liberty Latin America Class C in Q4 2015 and held it in 4 quarters.
  • Howard Hughes Medical Institute's Liberty Latin America Class C position peaked at $82K in Q2 2016.
  • 239 funds tracked by Wall St. Rank held Liberty Latin America Class C as of Q4 2016.

Based on Howard Hughes Medical Institute's 13F filing for Q4 2016, filed 1 Feb 2017.